Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PI3K-IN-22 is a dual kinase inhibitor of PI3Kα and mTOR, with IC50s of 0.9 and 0.6 nM respectively. PI3K-IN-22 could be used in cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 263.00 | |
5 mg | 35 days | $ 1,140.00 | |
10 mg | 35 days | $ 1,980.00 | |
25 mg | 35 days | $ 4,450.00 |
Description | PI3K-IN-22 is a dual kinase inhibitor of PI3Kα and mTOR, with IC50s of 0.9 and 0.6 nM respectively. PI3K-IN-22 could be used in cancer. |
Targets&IC50 | mTOR:0.6 nM (IC50), PI3Kα:0.9 nM (IC50) |
Synonyms | CAY10626 |
Molecular Weight | 624.66 |
Formula | C31H35F3N8O3 |
CAS No. | 1202884-94-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO:PBS (pH 7.2) (1:10): 0.1 mg/mL
DMF: 15 mg/mL
DMSO: 15 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PI3K-IN-22 1202884-94-3 PI-3K-IN-22 CAY10626 CAY-10626 CAY 10626 PI3K IN 22 PI3KIN22 inhibitor inhibit